CfDNA-based copy-number dynamics during anti-PD1 treatment in metastatic triple negative breast cancer.

Cell Rep Med · 2025 · PMC12765946 · PMID 41406937

Europe PMC DOI

hedged sentence

0.1100

closest p · 2.2× alpha

0.1100

boldest claim

The sentences

an increasing trendp = 0.11not close (p > 0.1)

cfDNA levels showed no clear trend among responders, whereas an increasing trend was observed among non-responders (Δ = 4.62, p = 0.11; Figures S5 A and S5B).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.